Definitive Contract 75D30121C10593
Award Date
3/11/21
Potential Completion Date
3/10/22
Potential Value
$41M
Federal Agency
CDC Pittsburgh
Awardee
Fulgent Therapeutics LLC
Ultimate Awardee
Fulgent Genetics, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Temple City, CA 91780, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price definitive contract awarded by the Veterans Integrated Service Network 17 of the Department of Veterans Affairs to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for $1,010,000.00 and has a period of performance through September 30, 2028. The contract is for genetics testing services, including clinical genetic testing, germline genetic testing utilizing whole genome sequencing, custom gene...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for germline genetic testing services. The contract has a ceiling value of $95,817.89 and a period of performance through September 30, 2018. It was awarded as a total small business set-aside. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits and services to various federal agencies, including the VA,...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for the delivery of laboratory testing kits, with a ceiling value of $889,097.43 and a period of performance through December 30, 2024. There was no set-aside designation used for this award. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits...
This federal contract award to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, is a $935,715 firm fixed price purchase order for NEXT GEN TESTING AT MAMC, awarded by the U.S. Army Medical Command. The contract has a period of performance through September 30, 2019 and does not have a set-aside designation. Fulgent Therapeutics is a subsidiary of Fulgent Genetics, Inc., a provider of comprehensive genomic testing services to various federal agencies including the Department of...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for $201,500 to provide clinical genetic testing services for chronic kidney disease. The contract has a performance period through January 17, 2024. Fulgent Diagnostics is a division of Fulgent Genetics, Inc., which specializes in genetic and genomic testing services for the federal government, including the VA,...
This is a $2,849,000.00 Firm Fixed Price Delivery Order contract awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The contract provides for GERMLINE PGX MOLECULAR TESTING services with a period of performance through September 29, 2029. This award is part of a larger $99,032,828.20 multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract held by Fulgent Genetics with...
This is a $6,489,759.80 firm fixed price Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the Department of Veterans Affairs (VA) Strategic Acquisition Center to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc., for germline genetic testing services. The contract has a 3-year term through September 2025 and is not set-aside. The contract will provide national access to specialized comprehensive reference laboratory testing services, including mandatory...
This federal contract award, valued at $247,000.00, was issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Fulgent Genetics, Inc. for genetic testing services to support the VA Portland Health Care System. The contract is a firm-fixed-price purchase order with a period of performance through July 31, 2029. Fulgent Genetics, a for-profit organization specializing in advanced genetic testing and genomic services, has secured multiple...
Fulgent Therapeutics LLC was awarded a firm fixed price purchase order valued at approximately $2.7 million by the Federal Emergency Management Agency to provide COVID-19 testing kits and services in support of FEMA's At Home COVID-19 Testing Program. Under the contract, Fulgent Therapeutics will distribute 15,000 FDA-approved PCR test kits that can detect SARS-CoV-2 and allow for at-home sample collection, receive and process the samples within 72 hours of receipt, and securely report...
This definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Helix Opco LLC, a for-profit limited liability company located in San Mateo, California. The $81,891,810 firm fixed price contract is for genomic sequencing services to support COVID-19 tracking and research efforts. The contract has an ultimate completion date of April 28, 2025 and was awarded on May 16, 2022. No set-aside designation was used. Helix Opco has previously received other prime contracts...